| 000 | 01723 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517080121.0 | ||
| 264 | 0 | _c20170104 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep20500 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Cheng | |
| 245 | 0 | 0 |
_aNorcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway. _h[electronic resource] |
| 260 |
_bScientific reports _cFeb 2016 |
||
| 300 |
_a20500 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Protein c-ets-1 _xgenetics |
| 700 | 1 | _aLi, Zequn | |
| 700 | 1 | _aNiu, Zhengchuan | |
| 700 | 1 | _aNiu, Wei | |
| 700 | 1 | _aXu, Zongquan | |
| 700 | 1 | _aGao, Huijie | |
| 700 | 1 | _aNiu, Weibo | |
| 700 | 1 | _aWang, JiaYong | |
| 700 | 1 | _aHe, Zhaobin | |
| 700 | 1 | _aGao, Chao | |
| 700 | 1 | _aLin, Pengfei | |
| 700 | 1 | _aAgrez, Michael | |
| 700 | 1 | _aZhang, Zongli | |
| 700 | 1 | _aNiu, Jun | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 20500 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep20500 _zAvailable from publisher's website |
| 999 |
_c25703403 _d25703403 |
||